[1] Farinati F,Vanin V,Giacomin A,et al.BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group.Liver Int,2015,35: 223-231.
[2] 朱炳印,郭顺林,姚永杰,等.CT灌注成像在原发性肝癌的临床应用价值.中国CT和MRI杂志,2017,15: 145-148.
[3] 丛文铭,步宏,陈杰,等.原发性肝癌规范化病理诊断指南(2015版).临床与实验病理学杂志,2015,31: 241-246.
[4] 陶一明,冯铁诚,王志明.原发性肝癌患者TNM分期与术后生存关系:SEER数据库分析.中国普通外科杂志,2016,25: 952-956.
[5] 张百红,岳红云.实体瘤疗效评价标准简介.国际肿瘤学杂志,2016,43: 845-847.
[6] Goos JA,de Cuba EM,Coupé VM,et al.Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.Ann Surg,2016,263: 138-145.
[7] Klotz E,Haberland U,Glatting G,et al.Technical prerequisites and imaging protocols for CT perfusion imaging in oncology.Eur J Radiol,2015,84: 2359-2367.
[8] 梁长华,梁盼,刘甲,等.原发性肝癌320排容积CT全肿瘤灌注参数值与微血管密度及其与病理分级的相关性研究.临床放射学杂志,2017,36: 517-522. |
